Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.

× No keyword cloud information.

8 in total

1. A PRACTICAL AND SIMPLE EQUIVALENT FOR STUDENT'S T TEST OF STATISTICAL SIGNIFICANCE.

Authors: C A HOGBEN
Journal: J Lab Clin Med Date: 1964-11

2. RELATIVE ROLES OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEMS IN THE REFLEX CONTROL OF HEART RATE.

Authors: G GLICK; E BRAUNWALD
Journal: Circ Res Date: 1965-04 Impact factor: 17.367

3. Routine direct measurement of arterial pressure in unanesthetized rats.

Authors: J R WEEKS; J A JONES
Journal: Proc Soc Exp Biol Med Date: 1960 Aug-Sep

4. Influence of an adrenergic beta-receptor blocking agent on the effect of various hypotensive agents in the hypertensive rat.

Authors: H Brunner; P R Hedwall; M Meier
Journal: Experientia Date: 1965-04-15

5. Inhibition of acute effects of hydralazine by an adrenergic beta-receptor blocking agent.

Authors: H Brunner; P R Hedwall; M Meier
Journal: Experientia Date: 1965-03-15

6. Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.

Authors: D H STEIN; H H HECHT
Journal: J Clin Invest Date: 1955-06 Impact factor: 14.808

7. [Experimental studies on the effects of the hypotension provoking hydrazinophthalazine derivatives apresoline and nepresol on blood circulation].

Authors: H J BEIN; F GROSS; J TRIPOD; R MEIER
Journal: Schweiz Med Wochenschr Date: 1953-04-04

8. Further cardiovascular and renal hemodynamic studies following the administration of hydralazine (1-hydrazinophthalazine) and the effect of ganglionic blockade with hexamethonium on these responses.

Authors: J H MOYER; R A HUGGINS; C A HANDLEY
Journal: J Pharmacol Exp Ther Date: 1953-10 Impact factor: 4.030

8 in total

1. The mechanism of the inhibitory action of adrenaline on the mammary gland.

Authors: G W Bisset; B J Clark; G P Lewis
Journal: Br J Pharmacol Chemother Date: 1967-11

2. Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors: D P Nicholls; D W Harron; R G Shanks
Journal: Br J Clin Pharmacol Date: 1983-01 Impact factor: 4.335

3. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.

Authors: W Aenishänslin; J Pestalozzi-Kerpel; U C Dubach; P R Imhof; M Turri
Journal: Eur J Clin Pharmacol Date: 1972-06 Impact factor: 2.953

4. Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.

Authors: W M Edmonstone; K K Manghani; A J Bell; M McLeod; G J Milton-Thompson; W L Burland
Journal: Br J Clin Pharmacol Date: 1981-10 Impact factor: 4.335

5. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.

Authors: W A Pettinger; K Keeton
Journal: J Clin Invest Date: 1975-02 Impact factor: 14.808

6. Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors: M Motolese; G Muiesan; A Colombi
Journal: Eur J Clin Pharmacol Date: 1975 Impact factor: 2.953

7. Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.

Authors: P Pancera; E Arosio; F Priante; M Ribul; M Zannoni; G Talamini; A Lechi
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

Review 8. Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors: J P Mulrow; M H Crawford
Journal: Clin Pharmacokinet Date: 1989-02 Impact factor: 6.447

8 in total